We are a global leader in the development of novel technologies and products which enable the high-quality and high-yield production of the world’s most-used diagnostic imaging isotopes.
Our flagship product, an award-winning hardware and consumable system called the QUANTM Irradiation System® (QIS®) provides for cost-effective, decentralized, and local production of important medical isotopes, such as Gallium-68, Zirconium-89, Technetium-99m and Copper-64 using existing hospital or commercially based medical cyclotrons empowering the user to control their supply chain
-
Reliable high-volume daily isotope production
- A single six-hour 99mTc run can produce 1000 patient doses at a fraction of current cost
-A single 90-minute 68Ga production can yield more than 100 patient doses and can be produced for as little as 5% of current cost -
Compatibility to all major cyclotron OEMs
The ARTMS System can be installed on new and existing cyclotron systems, including the 560 high energy cyclotrons already operational globally
-
Easily adaptable to new drugs coming to market
No infrastructure changes required
-
World-wide intellectual property protection
-
Established proprietary target processing methods
-
Novel purification and formulation processes on OEM synthesis units
-
Favorable supply agreements in place for raw materials
-
Environmentally benign. No long-lived, radioactive waste. Recycling of raw materials established
Certifications
Contact Our Sales Team
Our customers benefit directly from the intellectual property, know-how, trade-secrets, regulatory package and proprietary consumables we have developed.